"10.1371_journal.pone.0088406","plos one","2014-02-07T00:00:00Z","Gili Regev-Yochay; Galia Rahav; Klaris Riesenberg; Yonit Wiener-Well; Jacob Strahilevitz; Michal Stein; Daniel Glikman; Gabriel Weber; Israel Potasman; Ron Dagan; for the IAIPD study group","Infectious Disease Unit, Sheba Medical Center, Ramat-Gan, Israel; Infectious Disease Soroka University Medical Center, Beer-Sheva, Israel; Infectious Disease Unit, Shaare Zedek Medical Center, Jerusalem, Israel; Department of Clinical Microbiology & Infectious Disease, Hadassah-Hebrew University, Jerusalem, Israel; Pediatric Infectious Disease Unit, Wolfson Medical Center, Holon, Israel; Pediatric Infectious Disease Service, Western Galilee Hospital, Nahariya, Israel; Infectious Disease Unit, Carmel Medical Center, Haifa, Israel; Infectious Disease Unit, Bnei-Zion Medical Center, Haifa, Israel; Pediatric Infectious Diseases Unit, Soroka University Medical Center & Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel","Conceived and designed the experiments: GRY RD. Performed the experiments: GR KR YWW JS MS DG GW IP IAIPD study Group. Analyzed the data: GRY RD. Contributed reagents/materials/analysis tools: GRY RD. Wrote the paper: GRY RD GR JS DG YWW MS.","The study was supported in part by Wyeth (Pfizer), manufacture of Prevnar7 and Prevnar13, GRY served as a consultant of Neopharm, and Pfizer, GR served as a consultant of MSD, AstraZenica, Pfizer and Astellas. KR, YWW, JS, MS, DG, GW and IP â€“ no potential conflict of interest, RD has received grants/research support from Berna/Crucell, Wyeth/Pfizer, MSD, Protea; has been a scientific consultant for Berna/Crucell, GlaxoSmithKline, Novartis, Wyeth/Pfizer, Protea, MSD and a speaker for Berna/Crucell, GlaxoSmithKlien, Wyeth/Pfizer; he is a shareholder of Protea/NASVAX. The authors have declared that no competing interests exist. This does not alter our adherence to all PLOS ONE policies on sharing data and materials.","2014","02","Gili Regev-Yochay","GRY",11,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
